Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
In patients with atrial fibrillation, rivaroxaban was noninferior to warfarin for the prevention of stroke or systemic embolism. There was no significant between-group differenc...
Publications
1 shownFrequent Co-Authors
Researcher Info
- h-index
- 1
- Publications
- 1
- Citations
- 9,184
- Institution
- Johnson & Johnson (United States)
External Links
Identifiers
- ORCID
- 0000-0001-6396-7022
Impact Metrics
h-index
1
h-index: Number of publications with at least h citations each.